71 related articles for article (PubMed ID: 22890718)
1. The role and contributions of systems biology to the non-human primate model of influenza pathogenesis and vaccinology.
Baskin C
Curr Top Microbiol Immunol; 2013; 363():69-85. PubMed ID: 22890718
[TBL] [Abstract][Full Text] [Related]
2. The Future of Flu: A Review of the Human Challenge Model and Systems Biology for Advancement of Influenza Vaccinology.
Sherman AC; Mehta A; Dickert NW; Anderson EJ; Rouphael N
Front Cell Infect Microbiol; 2019; 9():107. PubMed ID: 31065546
[No Abstract] [Full Text] [Related]
3. Systems biology of influenza: understanding multidimensional interactions for personalized prevention and treatment.
Yan Q
Methods Mol Biol; 2010; 662():285-302. PubMed ID: 20824477
[TBL] [Abstract][Full Text] [Related]
4. 'Omics investigations of HIV and SIV pathogenesis and innate immunity.
Palermo RE; Fuller DH
Curr Top Microbiol Immunol; 2013; 363():87-116. PubMed ID: 22923094
[TBL] [Abstract][Full Text] [Related]
5. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.
Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK
J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789
[TBL] [Abstract][Full Text] [Related]
6. Animal models for evaluation of influenza vaccines.
Tripp RA; Tompkins SM
Curr Top Microbiol Immunol; 2009; 333():397-412. PubMed ID: 19768416
[TBL] [Abstract][Full Text] [Related]
7. Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease.
Khurana S; Loving CL; Manischewitz J; King LR; Gauger PC; Henningson J; Vincent AL; Golding H
Sci Transl Med; 2013 Aug; 5(200):200ra114. PubMed ID: 23986398
[TBL] [Abstract][Full Text] [Related]
8. A dynamical model for influenza under seasonal variables.
Taherian M; Toomanian M; Molaei M
Theor Biol Forum; 2014; 107(1-2):151-62. PubMed ID: 25936220
[TBL] [Abstract][Full Text] [Related]
9. Emergence of H7N9 Influenza A Virus Resistant to Neuraminidase Inhibitors in Nonhuman Primates.
Itoh Y; Shichinohe S; Nakayama M; Igarashi M; Ishii A; Ishigaki H; Ishida H; Kitagawa N; Sasamura T; Shiohara M; Doi M; Tsuchiya H; Nakamura S; Okamatsu M; Sakoda Y; Kida H; Ogasawara K
Antimicrob Agents Chemother; 2015 Aug; 59(8):4962-73. PubMed ID: 26055368
[TBL] [Abstract][Full Text] [Related]
10. Annual influenza vaccination affects the development of heterosubtypic immunity.
Bodewes R; Fraaij PL; Kreijtz JH; Geelhoed-Mieras MM; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
Vaccine; 2012 Dec; 30(51):7407-10. PubMed ID: 22643217
[TBL] [Abstract][Full Text] [Related]
11. Induction of broadly neutralizing H1N1 influenza antibodies by vaccination.
Wei CJ; Boyington JC; McTamney PM; Kong WP; Pearce MB; Xu L; Andersen H; Rao S; Tumpey TM; Yang ZY; Nabel GJ
Science; 2010 Aug; 329(5995):1060-4. PubMed ID: 20647428
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of primate models for AIDS.
Haigwood NL
AIDS Rev; 2004; 6(4):187-98. PubMed ID: 15700617
[TBL] [Abstract][Full Text] [Related]
13. Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza.
Huber VC; McKeon RM; Brackin MN; Miller LA; Keating R; Brown SA; Makarova N; Perez DR; Macdonald GH; McCullers JA
Clin Vaccine Immunol; 2006 Sep; 13(9):981-90. PubMed ID: 16960108
[TBL] [Abstract][Full Text] [Related]
14. Intranasal vaccination with a plant-derived H5 HA vaccine protects mice and ferrets against highly pathogenic avian influenza virus challenge.
Major D; Chichester JA; Pathirana RD; Guilfoyle K; Shoji Y; Guzman CA; Yusibov V; Cox RJ
Hum Vaccin Immunother; 2015; 11(5):1235-43. PubMed ID: 25714901
[TBL] [Abstract][Full Text] [Related]
15. Overcoming limitations in the systems vaccinology approach: a pathway for accelerated HIV vaccine development.
Zak DE; Aderem A
Curr Opin HIV AIDS; 2012 Jan; 7(1):58-63. PubMed ID: 22156843
[TBL] [Abstract][Full Text] [Related]
16. Unravelling the genetic components involved in the immune response of pigs vaccinated against influenza virus.
Zanella R; Gava D; Peixoto Jde O; Schaefer R; Ciacci-Zanella JR; Biondo N; da Silva MV; Cantão ME; Ledur MC
Virus Res; 2015 Dec; 210():327-36. PubMed ID: 26362524
[TBL] [Abstract][Full Text] [Related]
17. Correlations between lung proinflammatory cytokine levels, virus replication, and disease after swine influenza virus challenge of vaccination-immune pigs.
Van Reeth K; Van Gucht S; Pensaert M
Viral Immunol; 2002; 15(4):583-94. PubMed ID: 12513929
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of trivalent inactivated influenza vaccines in the cotton rat Sigmodon hispidus model.
Yim K; Miles B; Zinsou R; Prince G; Boukhvalova M
Vaccine; 2012 Feb; 30(7):1291-6. PubMed ID: 22210139
[TBL] [Abstract][Full Text] [Related]
19. Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong.
Cowling BJ; Ng S; Ma ES; Cheng CK; Wai W; Fang VJ; Chan KH; Ip DK; Chiu SS; Peiris JS; Leung GM
Clin Infect Dis; 2010 Dec; 51(12):1370-9. PubMed ID: 21067351
[TBL] [Abstract][Full Text] [Related]
20. Systems biology as a conceptual framework for research in family medicine; use in predicting response to influenza vaccination.
Majnarić-Trtica L; Vitale B
Prim Health Care Res Dev; 2011 Oct; 12(4):310-21. PubMed ID: 22284946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]